Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access

Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

R Andrew Moore* and Henry J McQuay

Arthritis Research & Therapy 2005, 7:R1046-R1051 doi:10.1186/ar1782

Accesses  

  • Last 30 days: 55 accesses
  • Last year: 1010 accesses
  • All time: 7977 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports

R Andrew Moore, Sheena Derry, Henry J McQuay Arthritis Research & Therapy 2008, 10:R53 (8 May 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access Highly Accessed

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk

R Andrew Moore, Sheena Derry, Henry J McQuay BMC Musculoskeletal Disorders 2007, 8:73 (3 August 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | Editor’s summary

While the absolute risk for upper gastrointestinal events is higher with nonsteroidal anti-inflammatory drugs than with cyclo-oxygenase 2 selective inhibitors, the rates of serious cardiovascular events are approximately equal.

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations